GPGiorgio Pashalidis

Giorgio Pashalidis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giorgio Pashalidis has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Alessandro Libra

    Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Diseases, Policlinico “G.Rodolico-San Marco”, University of Catania, 95123 Catania, Italy

    1 shared publication
  • Carlo Vancheri

    Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Diseases, Policlinico “G.Rodolico-San Marco”, University of Catania, 95123 Catania, Italy

    1 shared publication
  • Chiara Alfia Ferrara

    Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Disease, Policlinico “G. Rodolico-San Marco”, University of Catania, 95123 Catania, Italy

    1 shared publication
  • Domenico Sambataro

    Artroreuma S.R.L., Outpatient of Rheumatology Associated with the National Health System corso S. Vito 53, 95030 Mascalucia, Italy

    1 shared publication
  • Federica Libra

    Department of Medical Surgical Sciences and Advanced Technologies - Radiology I Unit, University Hospital "Policlinico-Vittorio Emanuele", Via Santa Sofia 78, Catania, 95123, Italy

    1 shared publication
  • Gianluca Sambataro

    Regional Referral Center for Rare Lung Disease, Policlinico "G. Rodolico‐San Marco" University of Catania Catania Italy

    1 shared publication

Latest Publications

  • Open Access

    The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis

    by Alessandro Libra, Michele Colaci, Lucia Spicuzza, Giuliana Luca, Sefora Fischetti, Giorgio Pashalidis, Chiara Alfia Ferrara, Giuseppe Ielo, Domenico Sambataro, Giuliana La Rosa, et al.

    Background: We proposed the term “UIPAF” to define patients with Usual Interstitial Pneumonia (UIP) associated with only one domain of the classification called “Interstitial Pneumonia with Autoimmune Features” (IPAF). The objective of this study was to evaluate the clinical presentation and prognosis of UIPAF patients, compared with two cohorts, composed of IPAF and idiopathic pulmonary fibrosis (IPF) patients, respectively. Methods: The patients were enrolled as IPAF, UIPAF, or IPF based on clinical, serological, and radiological data and evaluated by a multidisciplinary team. Results: We enrolled 110 patients with IPF, 69 UIPAF, and 123 IPAF subjects. UIPAF patients were similar to IPAF regarding autoimmune features, except for the prevalence of Rheumatoid Factor in UIPAF and anti-SSA in IPAF. A similar proportion of the two cohorts progressed toward a specific autoimmune disease (SAD), with differences in the kind of SAD developed. The real-life management and prognosis of UIPAF patients proved to be almost identical to IPF. Conclusions: UIPAF shared with IPAF similar autoimmune features, suggesting the opportunity to be considered IPAF, excluding the morphological domain by the classification. However, the real-life management and prognosis of UIPAF are similar to IPF. These data suggest a possible modification in the therapeutic management of UIPAF.